EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy (Copenhagen) 2020-12, Vol.75 (12), p.3287-3289
Hauptverfasser:	Bakker, Daphne S., Ariens, Lieneke F. M., Giovannone, Barbara, Hijnen, DirkJan, Delemarre, Eveline M., Knol, Edward, Nierkens, Stefan, Bruin‐Weller, Marjolein S., Thijs, Judith L., Drylewicz, Julia
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Atopic dermatitis Biological Products - therapeutic use biologics biomarkers Biomarkers - blood Dermatitis, Atopic - blood Dermatitis, Atopic - diagnosis Dermatitis, Atopic - drug therapy Dermatologic Agents - therapeutic use Humans Letter to the Editor Letters to the Editor Monoclonal antibodies Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!